International guidelines

United Kingdom

Diagnosis and management of Waldenström macroglobulinaemia - a British Society for Haematology guideline

Published by:British Society for Haematology

Last published:2022

Management of cardiovascular complications of Bruton tyrosine kinase inhibitors

Published by:British Society for Haematology

Last published:2021

Europe

Waldenström’s macroglobulinaemia: ESMO clinical practice guidelines for diagnosis, treatment and follow-up

Published by:European Society for Medical Oncology

Last published:2018

North America

Clinical practice guidelines in oncology: hematopoietic cell transplantation (HCT)

Published by:National Comprehensive Cancer Care Network

Last published:2024

Clinical practice guidelines in oncology: Waldenström macroglobulinemia/lymphoplasmacytic lymphoma

Published by:National Comprehensive Cancer Care Network

Last published:2023

Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines

Published by:Mayo Foundation for Medical Education and Research (Mayo Clinic)

Last published:2023

Rest of the world

Treatment recommendations from the tenth International Workshop on Waldenström's Macroglobulinemia

Published by:International Workshop on Waldenström's Macroglobulinemia

Last published:2020

Use of this content is subject to our disclaimer